In the following published article from the Journal of Neurochemistry, entitled “Fine‐tuning PERK signaling for neuroprotection” by Mark Halliday, Daniel Hughes, Giovanna R. Mallucci (J. Neurochem., 142: 812–826. doi.org/10.1111/jnc.14112), Dr. Helois Radford‐Rose, on behalf of Dr. Giovanna Mallucci, the corresponding author, would like to acknowledge that Dr. Mallucci is ERC funded. ERC asked the authors to add European Research Council (ERC) as a funding support source of the manuscript.
The updated Acknowledgements and conflict of interest disclosure is shown below:
This work was supported by European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement UPR Neuro, No. 647479). Disclosure GRM is funded by the Medical Research Council (MRC 5TR50), by a combined award from the Alzheimer's Society & Alzheimer's Drug Discovery Foundation (RG78185), by ERC Consolidator award (UPR Neuro) and by the UK DRI. The authors declare no conflicts of interest.
The authors would like to apologize for any inconvenience caused.
Reference
- Halliday M., Hughes D. and Mallucci G. R. (2017) Fine‐tuning PERK signaling for neuroprotection. J. Neurochem. 142, 812–826. 10.1111/jnc.14112. [DOI] [PMC free article] [PubMed] [Google Scholar]